These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8507912)

  • 1. Neurologic consequences of hypoglycemia and pathogenic mechanisms involved in diabetic neuropathy.
    Heller S; Ward JD
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):423-8. PubMed ID: 8507912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, classification, and treatment of diabetic peripheral neuropathy.
    Veves A; Sarnow MR
    Clin Podiatr Med Surg; 1995 Jan; 12(1):19-30. PubMed ID: 7720030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness.
    Heller SR; Macdonald IA
    Diabet Med; 1996 Jul; 13(7):607-15. PubMed ID: 8840093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo measurements of brain glucose transport using the reversible Michaelis-Menten model and simultaneous measurements of cerebral blood flow changes during hypoglycemia.
    Choi IY; Lee SP; Kim SG; Gruetter R
    J Cereb Blood Flow Metab; 2001 Jun; 21(6):653-63. PubMed ID: 11488534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral and central neurologic complications in type 2 diabetes mellitus: no association in individual patients.
    Manschot SM; Biessels GJ; Rutten GE; Kessels RP; Gispen WH; Kappelle LJ;
    J Neurol Sci; 2008 Jan; 264(1-2):157-62. PubMed ID: 17850822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic neuropathy in children and adolescents.
    Trotta D; Verrotti A; Salladini C; Chiarelli F
    Pediatr Diabetes; 2004 Mar; 5(1):44-57. PubMed ID: 15043690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to ameliorate the problem of hypoglycemia in intensive as well as nonintensive treatment of type 1 diabetes.
    Bolli GB
    Diabetes Care; 1999 Mar; 22 Suppl 2():B43-52. PubMed ID: 10097899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycaemia unawareness and the brain.
    Smith D; Amiel SA
    Diabetologia; 2002 Jul; 45(7):949-58. PubMed ID: 12136393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteine-induced hypoglycemic brain damage: an alternative mechanism to excitotoxicity.
    Gazit V; Ben-Abraham R; Coleman R; Weizman A; Katz Y
    Amino Acids; 2004 Mar; 26(2):163-8. PubMed ID: 15042446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetic encephalopathy: an underexposed complication of diabetes mellitus].
    Brands AM; Henselmans JM; de Haan EH; Biessels GJ
    Ned Tijdschr Geneeskd; 2003 Jan; 147(1):11-4. PubMed ID: 12564291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurologic manifestations of diabetes mellitus: an overview].
    Berek K; Luef G; Grubwieser G; Aichner F
    Wien Klin Wochenschr; 1994; 106(5):128-35. PubMed ID: 8171868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the onset and progression of peripheral neuropathy and hypertension in NIDDM].
    Jarmuzewska EA; Ghidoni A
    Minerva Med; 2000; 91(1-2):1-15. PubMed ID: 10858728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycaemia and cognitive function.
    Warren RE; Frier BM
    Diabetes Obes Metab; 2005 Sep; 7(5):493-503. PubMed ID: 16050942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic neuropathies.
    Low PA; Suarez GA
    Baillieres Clin Neurol; 1995 Nov; 4(3):401-25. PubMed ID: 8599718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetic neuropathy].
    Chudzik W; Kaczorowska B; Przybyła M; Chudzik B; Gałka M
    Pol Merkur Lekarski; 2007 Jan; 22(127):66-9. PubMed ID: 17477095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pathogenesis of diabetic and hepatic neuropathies].
    Winkler G; Kempler P
    Orv Hetil; 2001 Nov; 142(45):2459-67. PubMed ID: 11778353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic neuropathy: therapies for peripheral and autonomic symptoms.
    Emanuele NV; Emanuele MA
    Geriatrics; 1997 Apr; 52(4):40-2, 45-9. PubMed ID: 9119237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 2 weeks of theophylline on glucose counterregulation in patients with type 1 diabetes and unawareness of hypoglycemia.
    de Galan BE; Tack CJ; Lenders JW; Lutterman JA; Smits P
    Clin Pharmacol Ther; 2003 Jul; 74(1):77-84. PubMed ID: 12844138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of recurrent hypoglycemia on cognitive function in aging.
    McNay EC
    Neurobiol Aging; 2005 Dec; 26 Suppl 1():76-9. PubMed ID: 16236383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain glucose concentrations in patients with type 1 diabetes and hypoglycemia unawareness.
    Criego AB; Tkac I; Kumar A; Thomas W; Gruetter R; Seaquist ER
    J Neurosci Res; 2005 Jan 1-15; 79(1-2):42-7. PubMed ID: 15578722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.